Peter R van Dijk1, F Waanders2, Jiedong Qiu3, Hannah H R de Boer4, H van Goor5, H J G Bilo6. 1. Department of Endocrinology, University Medical Center, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. 2. Isala, Department of Internal Medicine, Zwolle, The Netherlands. 3. 5th Medical Department, Universitätsklinikum Mannheim, Mannheim, Germany. 4. Department of Endocrinology, University of Groningen, University Medical Center, Groningen, The Netherlands. 5. Department of Pathology and Medical Biology, University of Groningen, University Medical Center, Groningen, The Netherlands. 6. Department of Internal Medicine, University of Groningen, University Medical Center, Groningen, The Netherlands.
Abstract
BACKGROUND: Among persons with type 1 diabetes mellitus (T1DM) low concentrations of magnesium have been reported. Previous (small) studies also suggested a relation of hypomagnesemia with (poor) glycaemic control and complications. We aimed to investigate the magnitude of hypomagnesemia and the associations between magnesium with parameters of routine T1DM care in a population of unselected outpatients. METHODS: As part of a prospective cohort study, initially designed to measure quality of life and oxidative stress, data from 207 patients with a mean age of 45 [standard deviation (SD) 12] years, 58% male, diabetes duration 22 [interquartile range (IQR) 16, 31] years and glycated haemoglobin (HbA1c) of 60 (SD 11) mmol/mol [7.6 (SD 1.0)%] were examined. Hypomagnesemia was defined as a concentration below <0.7 mmol/l. RESULTS: Mean magnesium concentration was 0.78 (SD 0.05) mmol/l. A deficiency was present in 4.3% of participants. Among these persons, mean concentration was 0.66 (SD 0.03) mmol/l. There was no correlation between magnesium and HbA1c at baseline (r = -0.014, p = 0.843). In multivariable analysis, free thiols (reflecting the degree of oxidative stress) were significantly and negatively associated with magnesium concentrations. CONCLUSION: In this cohort of T1DM outpatients, the presence of hypomagnesemia was infrequent and, if present, relative mild. Magnesium was not associated with glycaemic control nor with presence of micro- and macrovascular complications. Although these results need confirmation, in particular the negative association of magnesium with free thiols, this suggests that hypomagnesemia is not a relevant topic in routine care for people with T1DM.
BACKGROUND: Among persons with type 1 diabetes mellitus (T1DM) low concentrations of magnesium have been reported. Previous (small) studies also suggested a relation of hypomagnesemia with (poor) glycaemic control and complications. We aimed to investigate the magnitude of hypomagnesemia and the associations between magnesium with parameters of routine T1DM care in a population of unselected outpatients. METHODS: As part of a prospective cohort study, initially designed to measure quality of life and oxidative stress, data from 207 patients with a mean age of 45 [standard deviation (SD) 12] years, 58% male, diabetes duration 22 [interquartile range (IQR) 16, 31] years and glycated haemoglobin (HbA1c) of 60 (SD 11) mmol/mol [7.6 (SD 1.0)%] were examined. Hypomagnesemia was defined as a concentration below <0.7 mmol/l. RESULTS: Mean magnesium concentration was 0.78 (SD 0.05) mmol/l. A deficiency was present in 4.3% of participants. Among these persons, mean concentration was 0.66 (SD 0.03) mmol/l. There was no correlation between magnesium and HbA1c at baseline (r = -0.014, p = 0.843). In multivariable analysis, free thiols (reflecting the degree of oxidative stress) were significantly and negatively associated with magnesium concentrations. CONCLUSION: In this cohort of T1DM outpatients, the presence of hypomagnesemia was infrequent and, if present, relative mild. Magnesium was not associated with glycaemic control nor with presence of micro- and macrovascular complications. Although these results need confirmation, in particular the negative association of magnesium with free thiols, this suggests that hypomagnesemia is not a relevant topic in routine care for people with T1DM.
Authors: Peter R van Dijk; Susan Jj Logtenberg; Klaas H Groenier; Joost C Keers; Henk Jg Bilo; Nanne Kleefstra Journal: World J Diabetes Date: 2014-08-15
Authors: Luis E Simental-Mendía; Amirhossein Sahebkar; Martha Rodríguez-Morán; Fernando Guerrero-Romero Journal: Pharmacol Res Date: 2016-06-18 Impact factor: 7.658
Authors: R M Walter; J Y Uriu-Hare; K L Olin; M H Oster; B D Anawalt; J W Critchfield; C L Keen Journal: Diabetes Care Date: 1991-11 Impact factor: 19.112